HBIO Stock Summary and Trading Ideas (Harvard Bioscience | NASDAQ:HBIO)

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

What symbol and exchange does Harvard Bioscience shares trade?

Harvard Bioscience trades on the NASDAQ stock market under the symbol HBIO.

What is Harvard Bioscience stock price doing today?

As of March 27, 2026, HBIO stock price declined to $4.87 with 39,235 million shares trading.

What is Harvard Bioscience's Beta?

HBIO has a beta of 2.35, meaning it tends to be more sensitive to market movements. HBIO has a correlation of 0.19 to the broad based SPY ETF.

How much is Harvard Bioscience worth?

HBIO has a market cap of $21.78 million. This is considered a Sub-Micro Cap stock.

How much money does Harvard Bioscience make?

Last quarter Harvard Bioscience reported $24 million in Revenue and $.00 earnings per share. This beat revenue expectation by $635,000 and missed earnings estimates by -$.30.

What is the highest and lowest price Harvard Bioscience traded in the last 3 year period?

In the last 3 years, HBIO traded as high as $62.90 and as low as $2.81.

What are the top ETFs holding Harvard Bioscience?

The top ETF exchange traded funds that HBIO belongs to (by Net Assets): VTI, VXF.

Is Harvard Bioscience (HBIO) a good investment?

HBIO has underperformed the market in the last year with a return of -18.8%, while the SPY ETF gained +13.1%. In the last 3 month period, HBIO fell short of the market, returning -30.7%, while SPY returned -7.9%. However, in the most recent 2 weeks HBIO has outperformed the stock market by returning +2.9%, while SPY returned -4.0%.

What are the support and resistance levels for Harvard Bioscience (HBIO)?

HBIO support price is $4.68 and resistance is $5.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HBIO shares will trade within this expected range on the day.